Landmarks in the evolution of prostate biopsy

[1]  F. Chun,et al.  Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out , 2022, European urology open science.

[2]  H. Ahmed,et al.  The unclear role of PET–CT in localized radiorecurrent prostate cancer , 2022, Nature Reviews Urology.

[3]  Jim C Hu,et al.  Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling. , 2022, European urology.

[4]  H. Ahmed,et al.  Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study , 2022, Diagnostics.

[5]  M. Cooperberg,et al.  Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. , 2021, Contemporary clinical trials.

[6]  A. Rastinehad,et al.  Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis , 2021, Prostate Cancer and Prostatic Diseases.

[7]  S. Punwani,et al.  ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI , 2021, BMJ Open.

[8]  D. Bruzzese,et al.  Prostate Health Index and Multiparametric MRI: Partners in Crime Fighting Overdiagnosis and Overtreatment in Prostate Cancer , 2021, Cancers.

[9]  S. Holdenrieder,et al.  Tumour markers in prostate cancer: The post-prostate-specific antigen era , 2021, Annals of clinical biochemistry.

[10]  H. Woo,et al.  The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study. , 2021, European urology.

[11]  M. Bartholomä,et al.  Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy , 2021, Biomolecules.

[12]  Daniela A. Ferraro,et al.  Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  C. Gündoğan,et al.  Correlations between whole body volumetric parameters of 68Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients , 2021, Annals of Nuclear Medicine.

[14]  A. Padhani,et al.  Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography , 2021, JAMA oncology.

[15]  T. Daskivich,et al.  Patient- and tumor-level risk factors for MRI-invisible prostate cancer , 2021, Prostate Cancer and Prostatic Diseases.

[16]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[17]  R. Szabo.  "Free-Hand" Transperineal Prostate Biopsy under Local Anesthesia: Review of the Literature. , 2020, Journal of endourology.

[18]  V. Khoo,et al.  Clinical Translation of Positive Metastases Identified on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging in the Management of De Novo Synchronous Oligometastatic Prostate Cancer. , 2020, European urology focus.

[19]  S. Hinz,et al.  Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia. , 2020, Urologic oncology.

[20]  H. G. van der Poel,et al.  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2020, European urology.

[21]  P. Dasgupta,et al.  Autonomous surgery in the era of robotic urology: friend or foe of the future surgeon? , 2020, Nature Reviews Urology.

[22]  Zheng Xu,et al.  68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  V. Gnanapragasam,et al.  Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study , 2020, Journal of clinical urology.

[24]  H. Ahmed,et al.  Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy , 2020, Translational andrology and urology.

[25]  F. Hamdy,et al.  Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. , 2020, European urology.

[26]  E. Frangou,et al.  What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort , 2020, European urology.

[27]  D. Gillatt,et al.  Robotic-assisted magnetic resonance imaging ultrasound fusion results in higher significant cancer detection compared to cognitive prostate targeting in biopsy naive men , 2020, Translational andrology and urology.

[28]  N. Vasdev,et al.  The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008–2019 , 2020, BJU international.

[29]  H. Ahmed,et al.  All change in the prostate cancer diagnostic pathway , 2020, Nature Reviews Clinical Oncology.

[30]  H. Ahmed,et al.  Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI , 2020, Prostate Cancer and Prostatic Diseases.

[31]  H. Woo,et al.  “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now , 2020, Prostate Cancer and Prostatic Diseases.

[32]  H. Ahmed,et al.  A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk. , 2020, European urology oncology.

[33]  G. Guazzoni,et al.  Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging. , 2020, European urology.

[34]  H. G. van der Poel,et al.  Histopathological Features of MRI‐Invisible Regions of Prostate Cancer Lesions , 2020, Journal of magnetic resonance imaging : JMRI.

[35]  H. Ahmed,et al.  Likert vs PI‐RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer , 2020, BJU international.

[36]  J. Bomers,et al.  Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy. , 2019, European urology.

[37]  N. Voutsinas,et al.  A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion‐guided biopsy: assessing the impact of inter‐reader variability on cancer detection , 2019, BJU international.

[38]  M. Allaf,et al.  Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results , 2019, World Journal of Urology.

[39]  S. Punwani,et al.  Similarities and differences between Likert and PIRADS v2.1 scores of prostate multiparametric MRI: a pictorial review of histology-validated cases. , 2019, Clinical radiology.

[40]  A. Sisk,et al.  Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. , 2019, JAMA surgery.

[41]  D. Margolis,et al.  Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. , 2019, European urology.

[42]  Kathleen E. Houlahan,et al.  Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer. , 2019, European urology.

[43]  J. Fütterer,et al.  Multiparametric magnetic resonance imaging and follow‐up to avoid prostate biopsy in 4259 men , 2019, BJU international.

[44]  A. Rosenkrantz,et al.  PI-RADS version 2.1: one small step for prostate MRI. , 2019, Clinical radiology.

[45]  F. Bruyère,et al.  Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry , 2019, World Journal of Urology.

[46]  H. Shinmoto,et al.  Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer , 2019, Modern Pathology.

[47]  M. Allaf,et al.  Incidentally Detected 18F-FDG-Avid Prostate Cancer Diagnosed Using a Novel Fusion Biopsy Platform. , 2019, Journal of endourology case reports.

[48]  R. V. D. van den Bergh,et al.  Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now? , 2019, Cancer treatment reviews.

[49]  Ian A. Donaldson,et al.  The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification , 2019, European urology.

[50]  D. Baltas,et al.  Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference , 2019, Theranostics.

[51]  J. Barentsz,et al.  The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. , 2019, European urology.

[52]  Christina Hulsbergen-van de Kaa,et al.  Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study. , 2019, European urology.

[53]  H. Ahmed,et al.  A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach , 2019, Journal of robotic surgery.

[54]  G. Marra,et al.  Combination of 68Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis , 2018, The Journal of Nuclear Medicine.

[55]  M. Allaf,et al.  In-office Transperineal Prostate Biopsy Using Biplanar Ultrasound Guidance: a Step-by-Step Guide. , 2019, Urology.

[56]  D. Nieboer,et al.  Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis. , 2020, European urology.

[57]  R. Popert,et al.  Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting , 2020, BJU international.

[58]  B. Ristau,et al.  Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template. , 2018, Urologic oncology.

[59]  D. Hawkes,et al.  Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial , 2018, The Journal of urology.

[60]  D. Jäger,et al.  Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer , 2018, Scientific Reports.

[61]  U. Nagele,et al.  Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations? , 2018, World Journal of Urology.

[62]  F. Saad,et al.  Landmarks in prostate cancer , 2018, Nature Reviews Urology.

[63]  H. Ahmed,et al.  Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study , 2018, The Journal of urology.

[64]  A. Rosenkrantz,et al.  The Institutional Learning Curve of Magnetic Resonance Imaging‐Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years , 2018, The Journal of urology.

[65]  Tristan Barrett,et al.  National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meeting , 2018, BJU international.

[66]  D. Mitchell,et al.  UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016 , 2018, Journal of contemporary brachytherapy.

[67]  A. Partin,et al.  Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System. , 2018, Urology.

[68]  T. Hermanns,et al.  Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer , 2018, The Journal of urology.

[69]  Osamu Ukimura,et al.  Diagnostic accuracy of a five‐point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image‐fusion targeted biopsy of the prostate , 2018, BJU international.

[70]  Nikolaos Dikaios,et al.  Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI. , 2017, The British journal of radiology.

[71]  Maarten de Rooij,et al.  Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis. , 2016, European urology focus.

[72]  E. Messing,et al.  A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens , 2018, The Journal of urology.

[73]  M. Schwaiger,et al.  Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[74]  Ian A. Donaldson,et al.  Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach , 2017, Prostate Cancer and Prostatic Diseases.

[75]  Carlos Nicolau,et al.  Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. , 2017, Radiology.

[76]  Marco Borghesi,et al.  Complications After Systematic, Random, and Image-guided Prostate Biopsy. , 2017, European urology.

[77]  Baris Turkbey,et al.  Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study , 2017, Journal of magnetic resonance imaging : JMRI.

[78]  M. Frydenberg,et al.  Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis , 2017, World Journal of Urology.

[79]  K. Nikolaou,et al.  First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy , 2017, World Journal of Urology.

[80]  Damien Bolton,et al.  Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. , 2016, European urology.

[81]  M. Roethke,et al.  Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. , 2016, European urology.

[82]  L. Marks,et al.  Some prostate cancers are invisible to magnetic resonance imaging! , 2016, BJU international.

[83]  H. Ahmed,et al.  Does true Gleason pattern 3 merit its cancer descriptor? , 2016, Nature Reviews Urology.

[84]  Tristan Barrett,et al.  Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool , 2016, BJU international.

[85]  Aytekin Oto,et al.  Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[86]  F. Kato,et al.  Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma , 2015, BMC Urology.

[87]  Nassir Navab,et al.  Multimodal image-guided prostate fusion biopsy based on automatic deformable registration , 2015, International Journal of Computer Assisted Radiology and Surgery.

[88]  M. Nykter,et al.  The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.

[89]  Jin Tae Kwak,et al.  Is Visual Registration Equivalent to Semiautomated Registration in Prostate Biopsy? , 2015, BioMed research international.

[90]  M. Emberton,et al.  Hospital admissions after transrectal ultrasound‐guided biopsy of the prostate in men diagnosed with prostate cancer: A database analysis in England , 2015, International journal of urology : official journal of the Japanese Urological Association.

[91]  J. Brooks,et al.  Biologic differences between peripheral and transition zone prostate cancer , 2015, The Prostate.

[92]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[93]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[94]  W. Shabana,et al.  Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI) , 2014, European Radiology.

[95]  P. Choyke,et al.  Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis. , 2014, Radiology.

[96]  Yair Lotan,et al.  Systematic review of complications of prostate biopsy. , 2013, European urology.

[97]  J. Fütterer,et al.  Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.

[98]  A. Zietman,et al.  Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. , 2013, Urologic oncology.

[99]  M. Roethke,et al.  Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics , 2013, BJU international.

[100]  Christiaan G Overduin,et al.  MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results , 2013, Current Urology Reports.

[101]  B. Carey,et al.  Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway☆ , 2013, Urologic oncology.

[102]  N. Giménez,et al.  Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis , 2012, Clinical chemistry and laboratory medicine.

[103]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[104]  P Mohan,et al.  Robotic transperineal prostate biopsy: pilot clinical study. , 2011, Urology.

[105]  Aaron Fenster,et al.  Clinical application of a 3D ultrasound-guided prostate biopsy system. , 2011, Urologic oncology.

[106]  A. Haese*,et al.  High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer , 2011, The Prostate.

[107]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[108]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[109]  B. Moran,et al.  Stereotactic transperineal prostate biopsy. , 2009, Urology.

[110]  Andrew J Vickers,et al.  A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden , 2008, BMC medicine.

[111]  Michael Phillips,et al.  Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. , 2008, The Journal of urology.

[112]  M. Melamed,et al.  Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience. , 2007, Urology.

[113]  K. Wallner,et al.  Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy. , 2006, European urology.

[114]  Clare Allen,et al.  How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.

[115]  A. Henderson,et al.  Extensive transperineal template biopsies of prostate: modified technique and results. , 2006, Urology.

[116]  W. Ellis,et al.  Improved prostate cancer detection with anterior apical prostate biopsies. , 2006, Urologic oncology.

[117]  N. Shinohara,et al.  Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound‐guided template prostate biopsy , 2005, Cancer.

[118]  D. Beyersdorff,et al.  MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. , 2005, Radiology.

[119]  K. Kihara,et al.  Transrectal ultrasound‐guided transperineal 14‐core systematic biopsy detects apico‐anterior cancer foci of T1c prostate cancer , 2004, International journal of urology : official journal of the Japanese Urological Association.

[120]  P. Humphrey,et al.  Gleason grading and prognostic factors in carcinoma of the prostate , 2004, Modern Pathology.

[121]  Shinya Yamamoto,et al.  Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5–20 ng/ml in Japan , 2004, International Journal of Clinical Oncology.

[122]  M. Lucia,et al.  Laterally directed biopsies detect more clinically threatening prostate cancer: Computer simulated results , 2003, The Prostate.

[123]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[124]  H. Wijkstra,et al.  Transrectal ultrasound imaging of the prostate: review and perspectives of recent developments , 1999, Prostate Cancer and Prostatic Diseases.

[125]  Daniel A. Levinthal,et al.  Innovation and Learning: The Two Faces of R&D , 1989 .

[126]  H. Hricak,et al.  MR imaging of the prostate gland: normal anatomy. , 1987, AJR. American journal of roentgenology.

[127]  J. McNeal.  The zonal anatomy of the prostate , 1981, The Prostate.

[128]  Hiroki Watanabe,et al.  Development and application of new equipment for transrectal ultrasonography , 1974, Journal of clinical ultrasound : JCU.

[129]  J. McNeal,et al.  Regional morphology and pathology of the prostate. , 1968, American journal of clinical pathology.

[130]  H. Grabstald.  Biopsy techniques in the diagnosis of cancer of the prostate , 1965, Ca.

[131]  R. S. Ferguson.  Prostatic neoplasms: Their diagnosis by needle puncture and aspiration , 1930 .

[132]  D. M. Davis,et al.  Young's Practice of Urology, Based on a Study of 12,500 Cases , 1927, The Indian Medical Gazette.